title: Prominent role of intracellular Ca2+ release in hypoxic vasoconstriction of canine pulmonary artery.
abstract: The possible role of sarcoplasmic reticulum (SR) Ca2+ stores in hypoxic pulmonary vasoconstriction (HPV) is not well understood. In order to assess the possible role of intracellular Ca2+ release from SR Ca2+ stores in HPV, we examined the effects of: (1) ryanodine (10 microM) depletion of intracellular Ca2+ stores, and (2) thapsigargin (THAPS, 2 microM) or cyclopiazonic acid (CPA, 10 microM) depletion of intracellular Ca2+ stores on HPV in canine pulmonary artery. 2 Isometric tension was measured from arterial ring suspended in Krebs-Henseliet solution (K-H) bubbled with 95%O2/5%CO2. Hypoxia was induced by bubbling phenylephrine (PE, 1 microM) precontracted rings with 95%N2/5%CO2. HPV was observed in both intact and endothelial-denuded arteries and expressed as % of maximal KCl contraction (% Tkmax) = 21.3 +/- 3.2%; n = 13 and 21.7 +/- 4%; n = 4 respectively. 3 When SR caffeine sensitive Ca2+ stores were depleted by pretreatment with ryanodine and brief caffeine (15 mM) exposure, the hypoxic response was significantly reduced to 19.1 +/- 9.2% of the control hypoxic contraction (n = 7; p < 0.001) with little or no effect on PE or KCl contractions. On the other hand, in normoxic rings pretreated with THAPS or CPA, the PE responses were significantly reduced (% Tkmax = 18.2 +/- 3.1% compared to 39.0 +/- 3.9% in control; n = 16; P < 0.001; %Tkmax = 3.4 +/- 1.6% compared to 49.9 +/- 7.9% in control; n = 6; P < 0.001; respectively) with no significant effect on caffeine-induced contractions, suggesting that both THAPS and CPA preferentially deplete InsP3-sensitive Ca2+ stores, without affecting the caffeine-sensitive Ca2+ store; consistent with the existence of separate and independent InsP3 and caffeine-sensitive Ca2+ stores in this preparation. 4 When hypoxia was induced in the presence of THAPS or CPA, developed tension was significantly larger than control (% Tkmax = 64.5 +/- 6.0%; n = 16; P < 0.05%; %Tkmax = 78.2 +/- 15%; n = 6; P < 0.05; respectively), was partially blocked by nisoldipine (10 microM) and ryanodine (% Tkmax = 20.3 +/- 3.7%; n = 6), and nearly completely blocked by SK&F 96365 (50 microM). However, the actions of SK&F 96365 appeared to be nonselective since this compound also significantly reduced contractions elicited by KCl, PE and caffeine. 5 Finally, evidence was obtained suggesting: (a) that at least some of the Ca2+ released from the caffeine- and ryanodine-sensitive Ca2+ stores by hypoxia may be taken up and buffered by the InsP3-sensitive Ca2+ stores, and (b) the apparent dependence of HPV on extracellular Ca2+ entry pathways may be partially due to the dependence of the Ca2+ content of intracellular SR Ca2+ stores on sarcolemmal Ca2+ entry pathways. 6 These data suggest that caffeine- and ryanodine-sensitive SR Ca2+ stores contribute significantly to HPV under normal conditions and, in the presence of THAPS or CPA, an additional nisoldipine- and ryanodine-insensitive Ca2+ entry pathway is evoked by hypoxia.
authors.affiliation: Department of Physiology & Cell Biology, University of Nevada School of Medicine, Reno 89557-0046, USA.
authors.forename: R I
authors.initials: RI
authors.lastname: Jabr
authors.forename: H
authors.initials: H
authors.lastname: Toland
authors.forename: C H
authors.initials: CH
authors.lastname: Gelband
authors.forename: X X
authors.initials: XX
authors.lastname: Wang
authors.forename: J R
authors.initials: JR
authors.lastname: Hume
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015687:Cell Hypoxia / Q000502:physiology; D004285:Dogs; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D010656:Phenylephrine / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D012433:Ryanodine / Q000494:pharmacology; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D019284:Thapsigargin / Q000494:pharmacology; D014661:Vasoconstriction / Q000502:physiology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D004791:Enzyme Inhibitors; D007211:Indoles; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D012433:Ryanodine; D010656:Phenylephrine; D019284:Thapsigargin; D002118:Calcium; C000543:cyclopiazonic acid